AB Science S.A (AB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.021x

Based on the latest financial reports, AB Science S.A (AB) has a cash flow conversion efficiency ratio of 0.021x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-207.00K ≈ $-242.00K USD) by net assets (€-9.81 Million ≈ $-11.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of AB Science S.A for the company's overall valuation and market capitalisation.

AB Science S.A - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how AB Science S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AB Science S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AB Science S.A ranked by their cash flow conversion efficiency. Explore earnings quality score of AB Science S.A to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
IL&FS Engineering and Construction Company Limited NSE:IL&FSENGG	0.015x
Y/KNOT S.A. AT:YKNOT	N/A
U-Tech Media Corp TW:3050	-0.001x
The Investment Trust Of India Limited NSE:THEINVEST	-0.433x
High Roller Technologies, Inc. NYSE MKT:ROLR	-0.012x
Playstudios Inc NASDAQ:MYPS	0.024x
Pollux Properti Indonesia Tbk PT JK:POLL	-0.007x
Iris Business Services Limited NSE:IRIS	0.012x

Annual Cash Flow Conversion Efficiency for AB Science S.A (2009–2025)

The table below shows the annual cash flow conversion efficiency of AB Science S.A from 2009 to 2025. View AB stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-9.81 Million ≈ $-11.47 Million	€-4.29 Million ≈ $-5.01 Million	0.437x	+2077.17%
2024-12-31	€-23.75 Million ≈ $-27.77 Million	€525.00K ≈ $613.78K	-0.022x	-102.75%
2023-12-31	€-21.01 Million ≈ $-24.56 Million	€-16.87 Million ≈ $-19.72 Million	0.803x	+63.95%
2022-12-31	€-35.67 Million ≈ $-41.70 Million	€-17.47 Million ≈ $-20.43 Million	0.490x	-33.86%
2021-12-31	€-23.20 Million ≈ $-27.12 Million	€-17.18 Million ≈ $-20.08 Million	0.740x	+7.14%
2020-12-31	€-19.55 Million ≈ $-22.85 Million	€-13.51 Million ≈ $-15.80 Million	0.691x	+22.34%
2019-12-31	€-26.83 Million ≈ $-31.37 Million	€-15.16 Million ≈ $-17.72 Million	0.565x	-68.45%
2018-12-31	€-14.96 Million ≈ $-17.49 Million	€-26.79 Million ≈ $-31.32 Million	1.791x	+183.96%
2017-12-31	€10.73 Million ≈ $12.55 Million	€-22.90 Million ≈ $-26.77 Million	-2.133x	-129.94%
2016-12-31	€-4.71 Million ≈ $-5.50 Million	€-33.52 Million ≈ $-39.19 Million	7.124x	+431.03%
2015-12-31	€-17.26 Million ≈ $-20.18 Million	€-23.16 Million ≈ $-27.07 Million	1.342x	+48.59%
2014-12-31	€-15.68 Million ≈ $-18.33 Million	€-14.16 Million ≈ $-16.55 Million	0.903x	+102.40%
2013-12-31	€341.00K ≈ $398.66K	€-12.84 Million ≈ $-15.01 Million	-37.639x	-2868.84%
2012-12-31	€4.90 Million ≈ $5.73 Million	€-6.21 Million ≈ $-7.26 Million	-1.268x	-17.81%
2011-12-31	€7.73 Million ≈ $9.04 Million	€-8.32 Million ≈ $-9.73 Million	-1.076x	-102.33%
2010-12-31	€14.78 Million ≈ $17.28 Million	€-7.86 Million ≈ $-9.19 Million	-0.532x	+92.87%
2009-12-31	€1.04 Million ≈ $1.22 Million	€-7.77 Million ≈ $-9.08 Million	-7.460x	--

About AB Science S.A

PA:AB France Drug Manufacturers - Specialty & Generic

Market Cap

$61.66 Million

€52.74 Million EUR

Market Cap Rank

#21670 Global

#339 in France

Share Price

€0.72

Change (1 day)

-1.37%

52-Week Range

€0.51 - €1.54

All Time High

€20.15